Boston Scientific to Participate in 11th Annual SVB Leerink Global Healthcare Conference

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

MARLBOROUGH, Mass., Feb. 14, 2022 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) will participate in SVB Leerink's 11th Annual Global Healthcare Conference on Thursday, February 17, 2022.

Metadata
Provider: 
PR NewswirePR Newswire
Retrieved on: 
Monday, February 14, 2022
Information
Tags: 
Boston Scientific, Health, NYSE, Patient, Webcast, SVB Leerink, Boston, Twitter, BSX, Jorge Scientific Corporation, Conference, Investor relations, Life, EST, Pharmaceutical industry, Facebook
Organisation: 
BOSTON SCIENTIFIC CORPORATION
Summary
Key Points: 
  • MARLBOROUGH, Mass., Feb. 14, 2022 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) will participate in SVB Leerink's 11th Annual Global Healthcare Conference on Thursday, February 17, 2022.
  • Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at approximately 9:20 a.m. EST.
  • A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com .
  • Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.


Boston Scientific to Participate in 11th Annual SVB Leerink Global Healthcare Conference

MARLBOROUGH, Mass., Feb. 14, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in SVB Leerink's 11th Annual Global Healthcare Conference on Thursday, February 17, 2022.

Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at approximately 9:20 a.m. EST. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.

The replay of the webcast will be accessible at investors.bostonscientific.com. beginning approximately one hour following the completion of the event.

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS                         

Media:                                   

Investors:

Kate Haranis                          

Lauren Tengler

508-683-6585 (office)            

508-683-4479 (office)

Media Relations                      

Investor Relations

Boston Scientific Corporation  

Boston Scientific Corporation

[email protected]           

[email protected]

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-11th-annual-svb-leerink-global-healthcare-conference-301481578.html

SOURCE Boston Scientific Corporation

Copyright: 
2022 PR Newswire. All Rights Reserved.